Tilray (NASDAQ:TLRY) Stock Price Up 0.8%

Tilray Inc (NASDAQ:TLRY) shares rose 0.8% on Monday . The stock traded as high as $1.87 and last traded at $1.84. Approximately 13,345,254 shares were traded during trading, a decline of 54% from the average daily volume of 29,081,066 shares. The stock had previously closed at $1.82.

Analyst Ratings Changes

TLRY has been the topic of several research reports. Alliance Global Partners upped their price objective on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th. Canaccord Genuity Group lowered their target price on shares of Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, CIBC lowered their target price on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a report on Wednesday, April 10th.

Tilray Price Performance

The company’s fifty day moving average price is $1.97 and its 200 day moving average price is $1.97. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11.

Institutional Trading of Tilray

A number of large investors have recently added to or reduced their stakes in TLRY. Clear Street Markets LLC purchased a new stake in Tilray during the third quarter worth about $25,000. Macquarie Group Ltd. increased its holdings in Tilray by 188.8% during the second quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock worth $27,000 after buying an additional 5,583 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new stake in Tilray during the fourth quarter worth about $27,000. Lake Street Financial LLC purchased a new stake in Tilray during the third quarter worth about $28,000. Finally, Gainplan LLC purchased a new stake in Tilray during the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.